DawnSMillinerMD

Nephrology • Rochester, MN

Hereditary Kidney Disease Genetics

Professor, Internal Medicine, Mayo Medical School Professor, Pediatrics, Mayo Medical School

Join to view full profile

Dr. Milliner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Milliner's full profile

Already have an account?

Office
200 1st St Sw
Rochester, MN 55905
Phone+1 507-284-2511

Education & Training

Children's Hospital Los AngelesFellowship, Pediatric Nephrology, 1981 - 1983
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Nephrology, 1980 - 1981
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1977 - 1979
Lewis Katz School of Medicine at Temple UniversityClass of 1976

Certifications & Licensure

MT State Medical License 2016 - 2026
MN State Medical License 1978 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria Start of enrollment: 2007 Dec 01
Withdrawn
Phase 3
Enteric Oxalate Absorption Study in Unclassified Hyperoxaluria Start of enrollment: 1998 Dec 01
Completed
Phase 1
Rare Kidney Stone Consortium Patient Registry Start of enrollment: 2003 Jul 01
Recruiting
Primary Hyperoxaluria Mutation Genotyping Start of enrollment: 2003 Dec 01
Completed
Study to Evaluate the Efficacy and Safety of OxabactTM on Reduction of Urinary Oxalate in Primary Hyperoxaluria Patients Start of enrollment: 2007 Oct 01
Completed
Phase 2, Phase 3
Phase 2/3 Oxabact Study Start of enrollment: 2009 Dec 01
Completed
Phase 2, Phase 3
Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Primary Hyperoxaluria Patients Who Are on Dialysis Start of enrollment: 2014 May 19
Completed
Phase 2
Rare Kidney Stone Consortium Biobank Start of enrollment: 2013 May 01
Recruiting
Hydroxyproline Influence on Oxalate Metabolism Start of enrollment: 2013 Sep 01
Completed
Phase 1, Phase 2
Health-related Quality of Life in Rare Kidney Stone Start of enrollment: 2013 Aug 01
Completed
Prospective Research Rare Kidney Stones (ProRKS) Start of enrollment: 2016 May 01
Recruiting
Join now to see all

Publications & Presentations

PubMed

164 citations
Hereditary Causes of Kidney Stones and Chronic Kidney Disease
Vidar O. Edvardsson, David S. Goldfarb, John C. Lieske, Lada Beara-Lasic, Franca Anglani
Pediatric Nephrology. 2013-01-20
200 citations
Urolithiasis in pediatric patients.
Dawn S. Milliner, Mary E. Murphy
Mayo Clinic Proceedings. 1993-03-01
165 citations
Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria
Katharina Hopp, Andrea G. Cogal, Eric J. Bergstralh, Barbara M. Seide, Julie B. Olson
Journal of the American Society of Nephrology. 2015-02-02

Press Mentions

Patient Access to Physician Notes Is Gaining MomentumMay 25th, 2016

Grant Support

Primary HyperoxaluriaNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
Hereditary Causes Of Nephrolithaisis And Kidney FailureNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
Prevention Of Renal Damage In Primary HyperoxaluriaNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2008
7th International Workshop On Primary HyperoxaluriaNational Institute Of Diabetes And Digestive And Kidney Diseases2005
Investigations Into The Phenotype And Genotype Of Atypical PrimaryNational Center For Research Resources2005
Determination Of WBC CystinosisNational Center For Research Resources2004–2005
Investigations Into Phenotype &Genotype Of Atypical Primary HyperoxaluriaNational Center For Research Resources1999–2002
Intravenous Gamma Globulin As An Agent To Lower AllosensitizationNational Center For Research Resources1999–2002
Compassionate Use Of Cysteamine In Nephropathic CystenosisNational Center For Research Resources1990–2002
Pilot Study Of Efficacy Of Procysteine In Treatment Of HyperoxaluriaNational Center For Research Resources1998–1999
Compassionate Use Of Cysteamine In Nephropathic CystinosisNational Center For Research Resources1992–1994
Effect Of Low Oxalate Diet On Urinary Excretion In Primary HyperoxaluriaNational Center For Research Resources1993
Compassionate Use Of Cysteamine In Patients With Nephropathic CystenosisNational Center For Research Resources1993
Glutamine On Urinary Cysteine ExeretionNational Center For Research Resources1988